3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Hemorrhage
2
Hematologic Neoplasms
2
Thrombocytopenia
1
Postoperative Hemorrhage
1
Pelvic Mass
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Colonic Neoplasms
1
Breast Neoplasms
1
Breast Cancer Females
1
Brain Neoplasms
1
Interventions
Tretinoin
2
apixaban
1
Tranexamic Acid
1
Tinzaparin
1
Sirolimus
1
Pluvicto
1
Observation
1
Enoxaparin
1
Dalteparin
1
Algorithms
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombocytopenia
×
Tranexamic Acid
×
1 year
×
Clear all
NCT06599762
2026-04-22
MYELO-CAN:TXA
University of Manitoba
Phase 2
Recruiting
75 enrolled